Widening Aims and Giving Patients a Voice for Expanded Structures in Breast Cancer Care Jointly Developed by Patients and Physicians
Launched by UNIVERSITY HOSPITAL AUGSBURG · May 10, 2024
Trial Information
Current as of February 08, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving the care and communication for patients with breast cancer. The project aims to understand how breast cancer care is currently being provided by looking at the experiences and needs of both patients and doctors. By gathering information from patient organizations and medical professionals, the trial seeks to identify areas where care can be improved. The goal is to create a better system for communication and support, ensuring that the needs of patients are at the forefront of breast cancer care.
To participate in this trial, individuals must be 18 years or older and have a confirmed diagnosis of breast cancer or ductal carcinoma in situ (DCIS). Doctors who treat breast cancer patients are also invited to join. Participants can expect to share their experiences and insights about communication and care, which will help shape future improvements in treatment and support for breast cancer patients. This is an opportunity for both patients and physicians to have their voices heard and contribute to better care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria (patients):
- • Breast cancer or DCIS
- • women and men aged 18 years and older
- Exclusion Criteria (patients):
- • women and men \< 18 years
- • no histologically confirmed breast cancer or DCIS diagnosis
- Inclusion Criteria (physicians):
- • - Treatment of breast cancer patients
Trial Officials
Nina Ditsch, Prof.
Principal Investigator
University Hospital Augsburg
About University Hospital Augsburg
University Hospital Augsburg is a leading academic medical center located in Augsburg, Germany, dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital integrates cutting-edge medical practices with rigorous scientific inquiry, fostering collaborations between multidisciplinary teams of researchers, clinicians, and patients. With a commitment to enhancing patient outcomes and contributing to the global medical community, University Hospital Augsburg emphasizes ethical standards, patient safety, and the development of novel therapeutic approaches in various fields of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Augsburg, Bayern, Germany
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0